Results 81 to 90 of about 1,090 (156)
Sustainability of Teprotumumab Efficacy in Thyroid Eye Disease
Teprotumumab, an insulin-like growth factor-I receptor inhibitory antibody, improved proptosis, diplopia, inflammatory signs/symptoms, and quality of life in thyroid eye disease (TED) patients in phase 2 and 3 (OPTIC) trials.1,2 OPTIC proptosis non ...
Prem S. Subramanian; Saba Sile; Robert Holt; Raymond Douglas
core +2 more sources
Médecine (endocrinologie, diabétologie et nutrition)L'orbitopathie est la manifestation extra-thyroïdienne la plus fréquente de la maladie de Basedow, engageant le pronostic visuel. La corticothérapie lV est recommandée dans les formes modérées à sévères
Herfeld, Grégoire
core
Purpose To compare the measurements of macular thickness, intraocular pressure and RNFL and hormone parameters before and after antithyroid therapy in patients with Graves’ Ophthalmopathy (GO).
Gamze Akkus +6 more
doaj +1 more source
Introduction This study aims to analyze risk factors for ocular surface irritation symptoms in patients with non-corneal-damage inactive mild and moderate-to-severe Graves’ orbitopathy (GO). Methods This retrospective study enrolled 307 patients with non-
Yun Yu +6 more
doaj +1 more source
Multidimensional predictive model for assessing clinical activity in thyroid eye disease
ObjectiveThyroid eye disease (TED) is an autoimmune disorder with complex inflammatory activity that remains challenging to assess accurately.
Yang Li +22 more
doaj +1 more source
Update on Graves’ ophthalmopathy
Trabalho Final do Curso de Mestrado Integrado em Medicina, Faculdade de Medicina, Universidade de Lisboa, 2016Oftalmopatia de Graves, doença ocular tiroideia ou orbitopatia tiroideia é uma patologia inflamatória autoimune que ocorre em aproximadamente 25%
Fernandes, Ana Sofia Cruz
core +2 more sources
BackgroundGraves' orbitopathy (GO) occurs in approximately 25-40% of patients with Graves' disease (GD). High levels of anti-thyrotropin receptor antibodies (TRAbs), smoking habit, sex, older age, longer duration and amount of hyperthyroidism or ...
Rosario Le Moli +9 more
doaj +1 more source
OBJECTIVE : To construct a predictive score for the development or progression of Graves’ orbitopathy (GO) in Graves’ hyperthyroidism (GH). DESIGN : Prospective observational study in patients with newly diagnosed GH, treated with antithyroid drugs (ATD)
Töröner, F. sun Baloş +106 more
core +1 more source
Graves oftalmopatide (GO) izlenen semptom, klinik bulgu ve ölçülen parametrelerdeki çeşitlilik, olgularda tedavi ve takip zorluklarına yol açmaktadır. 2003 yılında EUGOGO tarafından GO olgularının değerlendirilmesinde standardizasyonu sağlamak amacıyla ...
MİNE ÖZTÜRK KURTULMUŞOĞLU
core +2 more sources
Bednarczuk, Tomasz +27 more
+7 more sources

